Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Infections of the Upper Respiratory Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06642558
What this trial is testing

Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above

Who this might be right for
Respiratory Syncytial Virus (RSV)
MAXVAX Biotechnology Limited Liability Company 522
Post-approval studies (Phase 4)UnknownNCT05329038
What this trial is testing

Immunogenicity，Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 180
Post-approval studies (Phase 4)Study completedNCT01867021
What this trial is testing

Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above

Who this might be right for
Influenza
Novartis 2,902
Not applicableStudy completedNCT02644135
What this trial is testing

A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo

Who this might be right for
Healthy
University Hospitals Cleveland Medical Center 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05993325
What this trial is testing

Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers

Who this might be right for
COVID-19Vaccines
Cellid Co., Ltd. 4,000
Early research (Phase 1)Study completedNCT03275389
What this trial is testing

Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years

Who this might be right for
Influenza, Human
GlaxoSmithKline 470
Early research (Phase 1)Study completedNCT05067894
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine

Who this might be right for
Covid19
PT Bio Farma 54
Not applicableStudy completedNCT01033799
What this trial is testing

Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers

Who this might be right for
Infectious DiseasesHealthy SubjectsRespiratory Tract Infections+7 more
Danone Global Research & Innovation Center 1,000
Large-scale testing (Phase 3)Study completedNCT00016081
What this trial is testing

Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation

Who this might be right for
Infection
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT06251089
What this trial is testing

Effect of Cetylpyridinium Chloride (CPC) Rinse in Viral Upper Respiratory Tract Infections (vURTI)

Who this might be right for
Viral Pharyngitis
Dentaid SL 102
Not applicableStudy completedNCT04629989
What this trial is testing

Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19

Who this might be right for
Covid19Hypoxemia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 27
Large-scale testing (Phase 3)UnknownNCT05163652
What this trial is testing

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

Who this might be right for
SARS-CoV-2 Infection
Chinese Academy of Medical Sciences 432
Not applicableStudy completedNCT03535064
What this trial is testing

The Association of Hand Hygiene Practice on Primary Schoolgirls Absence Due to URIs in Riyadh City, 2017-2018.

Who this might be right for
Upper Respiratory Tract Infections
Abrar Alzaher 496
Large-scale testing (Phase 3)UnknownNCT05164731
What this trial is testing

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above

Who this might be right for
SARS-CoV2 Infection
Chinese Academy of Medical Sciences 880
Not applicableUnknownNCT04715854
What this trial is testing

Effect on paO2 of Adding an Aerosol Mask Above the Nasal Canulas

Who this might be right for
Hypoxemic Respiratory FailureEmergenciesCovid19
Laboratory of Movement, Condorcet, Tournai, Belgium 15
Not applicableStudy completedNCT03756753
What this trial is testing

The RAPID Trial: Assessing Point-of-care Influenza and Other Respiratory Virus Diagnostics

Who this might be right for
Respiratory PathogensUpper Respiratory Tract IllnessLower Respiratory Tract Illness+1 more
University of Colorado, Denver 913
Large-scale testing (Phase 3)Study completedNCT00345904
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above

Who this might be right for
Influenza
GlaxoSmithKline 120
Not applicableStudy completedNCT02640352
What this trial is testing

The Efficacy of a Probiotic Product on Acute Upper Respiratory Tract Infections (Common Cold) in Healthy Children

Who this might be right for
Acute Upper Respiratory Tract Infections (Common Cold)
Probi AB 550
Large-scale testing (Phase 3)Ended earlyNCT04860258
What this trial is testing

COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities

Who this might be right for
CoronavirusCovid19SARS-CoV-2+1 more
CureVac 129
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07712380
What this trial is testing

A Study Exploring the Effect of Adjuvanted RZV or RSVPreF3 Vaccines on Coronary Plaque Progression in Adults >=50 Years of Age at Risk for Cardiovascular Events

Who this might be right for
Cardiovascular Disease
GlaxoSmithKline 450
Next Page